Washington, D.C. 20549
[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For the quarterly period ended September 30, 2004. |
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For the transition period from to . |
Commission File Number 1-12273
ROPER INDUSTRIES, INC.
(Exact name of
registrant as specified in its charter)
Delaware | 51-0263969 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
2160 Satellite Blvd., Suite 200 Duluth, Georgia |
30097 |
(Address of principal executive offices) | (Zip Code) |
(770) 495-5100
(Registrants
telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes X No
The number of shares outstanding of the Registrants common stock as of November 1, 2004 was approximately 37,157,088.
Page | ||||||||
---|---|---|---|---|---|---|---|---|
PART I | FINANCIAL INFORMATION | |||||||
Item 1 | Financial Statements (unaudited): | |||||||
Condensed Consolidated Statements of Earnings | 3 | |||||||
Condensed Consolidated Balance Sheets | 4 | |||||||
Condensed Consolidated Statements of Cash Flows | 5 | |||||||
Condensed Consolidated Statements of Changes in Stockholders' Equity | 6 | |||||||
Notes to Condensed Consolidated Financial Statements | 7 | |||||||
Item 2 | Managements Discussion and Analysis of Financial Condition and Results of Operations | 13 | ||||||
Item 3 | Quantitative and Qualitative Disclosures About Market Risk | 22 | ||||||
Item 4 | Controls and Procedures | 23 | ||||||
PART II | OTHER INFORMATION | |||||||
Item 6 | Exhibits | 25 | ||||||
Signatures | 26 |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
2003 |
2004 |
2003 |
|||||||||||
Net sales | $ | 240,141 | $ | 172,064 | $ | 693,215 | $ | 487,562 | ||||||
Cost of sales | 120,570 | 78,894 | 348,191 | 230,504 | ||||||||||
Gross profit | 119,571 | 93,170 | 345,024 | 257,058 | ||||||||||
Selling, general and administrative expenses | 74,151 | 60,649 | 225,924 | 178,262 | ||||||||||
Income from operations | 45,420 | 32,521 | 119,100 | 78,796 | ||||||||||
Interest expense | 7,327 | 4,018 | 21,066 | 12,653 | ||||||||||
Other income/(expense) | (17 | ) | (239 | ) | 18 | (195 | ) | |||||||
Earnings from continuing operations before | ||||||||||||||
income taxes | 38,076 | 28,264 | 98,052 | 65,948 | ||||||||||
Income taxes | 10,694 | 8,479 | 28,986 | 19,784 | ||||||||||
Earnings from continuing operations | 27,382 | 19,785 | 69,066 | 46,164 | ||||||||||
Loss from discontinued operations, net of | ||||||||||||||
tax | -- | 1,912 | -- | 2,822 | ||||||||||
Net earnings | $ | 27,382 | $ | 17,873 | $ | 69,066 | $ | 43,342 | ||||||
Net earnings per share: | ||||||||||||||
Basic: | ||||||||||||||
Earnings from continuing operations | $ | 0.74 | $ | 0.63 | $ | 1.87 | $ | 1.47 | ||||||
Loss from discontinued operations | -- | (0.06 | ) | -- | (0.06 | ) | ||||||||
Net Earnings | $ | 0.74 | $ | 0.57 | $ | 1.87 | $ | 1.38 | ||||||
Diluted: | ||||||||||||||
Earnings from continuing operations | $ | 0.73 | $ | 0.62 | $ | 1.84 | $ | 1.45 | ||||||
Loss from discontinued operations | -- | (0.06 | ) | -- | (0.09 | ) | ||||||||
Net Earnings | $ | 0.73 | $ | 0.56 | $ | 1.84 | $ | 1.36 | ||||||
Weighted average common shares outstanding: | ||||||||||||||
Basic | 37,039 | 31,571 | 36,870 | 31,482 | ||||||||||
Diluted | 37,673 | 32,055 | 37,474 | 31,844 | ||||||||||
Dividends declared per common share | $ | 0.09625 | $ | 0.08750 | $ | 0.28875 | $ | 0.26250 |
See accompanying notes to condensed consolidated financial statements
September 30, 2004 |
December 31, 2003 |
|||||||
---|---|---|---|---|---|---|---|---|
ASSETS: | ||||||||
Cash and cash equivalents | $ | 102,416 | $ | 70,234 | ||||
Accounts receivable, net | 169,592 | 150,856 | ||||||
Inventories | 109,316 | 107,082 | ||||||
Deferred taxes | 20,671 | 33,314 | ||||||
Other current assets | 9,019 | 19,706 | ||||||
Total current assets | 411,014 | 381,192 | ||||||
Property, plant and equipment, net | 74,189 | 78,461 | ||||||
Goodwill | 739,418 | 711,158 | ||||||
Other intangible assets, net | 297,015 | 298,669 | ||||||
Deferred taxes | 10,828 | 6,034 | ||||||
Other noncurrent assets | 40,674 | 39,481 | ||||||
Total assets | $ | 1,573,138 | $ | 1,514,995 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY: | ||||||||
Accounts payable | $ | 46,165 | $ | 45,412 | ||||
Accrued liabilities | 80,012 | 93,523 | ||||||
Deferred taxes | 1,640 | 1,639 | ||||||
Current portion of long-term debt | 20,951 | 20,923 | ||||||
Total current liabilities | 148,768 | 161,497 | ||||||
Long-term debt | 594,746 | 630,186 | ||||||
Deferred taxes | 55,426 | 50,187 | ||||||
Other liabilities | 18,692 | 17,344 | ||||||
Total liabilities | 817,632 | 859,214 | ||||||
Common stock | 383 | 372 | ||||||
Additional paid-in capital | 333,989 | 293,461 | ||||||
Unearned compensation on restricted stock | (473 | ) | (59 | ) | ||||
Retained earnings | 394,908 | 336,520 | ||||||
Accumulated other comprehensive earnings | 49,931 | 48,989 | ||||||
Treasury stock | (23,232 | ) | (23,502 | ) | ||||
Total stockholders' equity | 755,506 | 655,781 | ||||||
Total liabilities and stockholders' equity | $ | 1,573,138 | $ | 1,514,995 | ||||
See accompanying notes to condensed consolidated financial statements
Nine months ended September 30, |
||||||||
---|---|---|---|---|---|---|---|---|
2004 |
2003 |
|||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ | 69,066 | $ | 43,342 | ||||
Depreciation | 13,437 | 8,556 | ||||||
Amortization | 16,390 | 3,550 | ||||||
Other, net | 2,666 | 2,322 | ||||||
Cash provided by operating activities | 101,559 | 57,770 | ||||||
Cash flows from investing activities: | ||||||||
Business acquisitions, net of cash acquired | (51,861 | ) | (1,654 | ) | ||||
Capital expenditures | (8,108 | ) | (8,084 | ) | ||||
Other, net | (3,521 | ) | (1,969 | ) | ||||
Cash used in investing activities | (63,490 | ) | (11,707 | ) | ||||
Cash flows from financing activities: | ||||||||
Debt payments, net | (34,954 | ) | (45,800 | ) | ||||
Issuance of common stock | 28,873 | -- | ||||||
Dividends | (10,678 | ) | (8,284 | ) | ||||
Other, net | 10,876 | 5,340 | ||||||
Cash used in financing activities | (5,883 | ) | (48,744 | ) | ||||
Effect of foreign currency exchange rate changes on cash | (4 | ) | 1,921 | |||||
Net increase/(decrease) in cash and cash equivalents | 32,182 | (760 | ) | |||||
Cash and cash equivalents, beginning of period | 70,234 | 15,270 | ||||||
Cash and cash equivalents, end of period | $ | 102,416 | $ | 14,510 | ||||
See accompanying notes to condensed consolidated financial statements
Common stock |
Additional paid-in capital |
Unearned compensation on restricted stock earnings |
Retained earnings |
Accumulated other comprehensive earnings |
Treasury stock |
Total |
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balances at December 31, 2003 | $ | 372 | $ | 293,461 | $ | (59 | ) | $ | 336,520 | $ | 48,989 | $ | (23,502 | ) | $ | 665,781 | |||||||
Net earnings | -- | -- | -- | 69,066 | -- | -- | 69,066 | ||||||||||||||||
Stock option transactions | 5 | 10,340 | -- | -- | -- | -- | 10,345 | ||||||||||||||||
Treasury stock sold | -- | 370 | -- | -- | -- | 270 | 640 | ||||||||||||||||
Currency translation adjustments | -- | -- | -- | -- | 942 | -- | 942 | ||||||||||||||||
Restricted stock grants | -- | 945 | (414 | ) | -- | -- | -- | 531 | |||||||||||||||
Issuance of common stock | 6 | 28,873 | -- | -- | -- | -- | 28,879 | ||||||||||||||||
Dividends declared | -- | -- | -- | (10,678 | ) | -- | -- | (10,678 | ) | ||||||||||||||
Balances at September 30, 2004 | $ | 383 | $ | 333,989 | $ | (473 | ) | $ | 394,908 | $ | 49,931 | $ | (23,232 | ) | $ | 755,506 | |||||||
See accompanying notes to condensed consolidated financial statements
The accompanying condensed consolidated financial statements for the three-month and nine-month periods ended September 30, 2004 and 2003 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position, results of operations and cash flows of Roper Industries, Inc. and its subsidiaries (Roper or the Company) for all periods presented.
Certain reclassifications have been made to previously reported information to conform to the current presentation.
Ropers management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP). Actual results could differ from those estimates.
The results of operations for the three-month and nine-month periods ended September 30, 2004 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Ropers consolidated financial statements and the notes thereto included in its 2003 Annual Report on Form 10-K filed with the Securities and Exchange Commission.
Basic earnings per share are calculated by dividing net earnings (there were no adjustments necessary to determine earnings available to common shares) by the weighted average number of common shares outstanding during the period. Diluted earnings per share included the dilutive effect of common stock equivalents outstanding during the period. Common stock equivalents consisted of stock options.
The FASB issued SFAS No. 148 Accounting for Stock-Based Compensation Transition and Disclosure, an amendment of FASB Statement No. 123 which provides alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, this statement amends certain disclosure requirements of Statement 123. Currently, Roper has chosen not to adopt the accounting provisions of SFAS 123; however, as permitted by SFAS 123, the Company continues to apply intrinsic value accounting for its stock option plans under Accounting Principles Board Opinion No. 25 (APB 25), Accounting for Stock Issued to Employees. Ropers pro forma net earnings and pro forma earnings per share based upon the fair value at the grant dates for awards under the Companys plans are disclosed below.
If the Company had elected to recognize compensation expense based upon the fair value at the grant dates for awards under these plans, the Companys pro forma net income and income per share would have been approximately as presented below.
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
2003 |
2004 |
2003 |
|||||||||||
Net earnings, as reported (in thousands) | $ | 27,382 | $ | 17,873 | $ | 69,066 | $ | 43,342 | ||||||
Add: Total additional stock based | ||||||||||||||
compensation included in net income | 354 | 59 | 532 | 59 | ||||||||||
Deduct: Total additional stock based | ||||||||||||||
compensation cost, net of tax | 3,114 | 1,216 | 8,460 | 3,397 | ||||||||||
Net earnings Pro forma (in thousands) | $ | 24,622 | $ | 16,716 | $ | 61,138 | $ | 40,004 | ||||||
Net Earnings per share, as reported: | ||||||||||||||
Basic | $ | 0.74 | $ | 0.57 | $ | 1.87 | $ | 1.38 | ||||||
Diluted | 0.73 | 0.56 | 1.84 | 1.36 | ||||||||||
Net Earnings per share, Pro forma: | ||||||||||||||
Basic | $ | 0.66 | $ | 0.53 | $ | 1.66 | $ | 1.27 | ||||||
Diluted | 0.65 | 0.52 | 1.63 | 1.26 |
Comprehensive earnings include net earnings and all other non-owner sources of changes in net assets. Comprehensive earnings (in thousands) for the three months ended September 30, 2004 and 2003 were $31,658 and $17,224, respectively, and $70,008 and $63,295 for the nine months ended September 30, 2004 and 2003 respectively. The differences between net earnings and comprehensive earnings were currency translation adjustments. Income taxes have not been provided on currency translation adjustments.
September 30, 2004 |
December 31, 2003 |
|||||||
---|---|---|---|---|---|---|---|---|
(in thousands) | ||||||||
Raw materials and supplies | $ | 76,264 | $ | 72,259 | ||||
Work in process | 17,419 | 17,158 | ||||||
Finished products | 41,758 | 42,841 | ||||||
Other inventory reserves | (24,801 | ) | (23,852 | ) | ||||
LIFO reserve | (1,324 | ) | (1,324 | ) | ||||
$ | 109,316 | $ | 107,082 | |||||
Instrumentation |
Industrial Technology |
Energy Systems & Controls |
Scientific & Industrial Imaging |
Total |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(in thousands) | |||||||||||||||||
Balances at December 31, 2003 | $ | 224,026 | $ | 284,745 | $ | 81,501 | $ | 120,886 | $ | 711,158 | |||||||
Additions | -- | 203 | 24,641 | 2,703 | 27,547 | ||||||||||||
Currency translation adjustments | (88 | ) | 117 | (54 | ) | 738 | 713 | ||||||||||
Balances at September 30, 2004 | $ | 223,938 | $ | 285,065 | $ | 106,088 | $ | 124,327 | $ | 739,418 | |||||||
The increase in goodwill in the Energy Systems and Controls segment relates to the acquisition of the power generation business of R/D Tech which closed on June 7, 2004. The purchase price was approximately $39,000 with gross assets of approximately $15,000 and gross liabilities of approximately $500.
Cost |
Accumulated amort. |
Net book value |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(in thousands) | |||||||||||||||||
Assets subject to amortization: | |||||||||||||||||
Existing customer base | $ | 230,721 | $ | (13,100 | ) | $ | 217,621 | ||||||||||
Unpatented technology | 1,980 | (606 | ) | 1,374 | |||||||||||||
Software | 26,171 | (5,318 | ) | 20,853 | |||||||||||||
Patents and other protective rights | 8,337 | (5,008 | ) | 3,329 | |||||||||||||
Trade secrets | 6,202 | (1,241 | ) | 4,961 | |||||||||||||
Sales order backlog | 500 | (500 | ) | -- | |||||||||||||
Assets not subject to amortization: | |||||||||||||||||
Trade names | 48,878 | -- | 48,878 | ||||||||||||||
Balances at September 30, 2004 | $ | 322,789 | $ | (25,774 | ) | $ | 297,015 | ||||||||||
Amortization expense of other intangible assets was $13,861 and $3,550 during the nine months ended September 30, 2004 and 2003, respectively.
Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including those pertaining to product liability and employment practices. It is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. Based upon Ropers past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on the consolidated financial position, results of operations or cash flows of Roper.
Over recent years there has been a significant increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and Roper believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.
The Companys financial statements include accruals for potential product liability and warranty claims based on the Companys claims experience. Such costs are accrued at the time revenue is recognized. A summary of the Companys warranty accrual activity for the nine months ended September 30, 2004 is presented below (in thousands).
Balance at December 31, 2003 | $ | 5,014 | |||
Additions charged to costs and expenses | 4,305 | ||||
Deductions | (4,233 | ) | |||
Other | 173 | ||||
Balance at September 30, 2004 | $ | 5,259 | |||
Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
2003 |
Change |
2004 |
2003 |
Change |
|||||||||||||||
Net sales: | ||||||||||||||||||||
Instrumentation | $ | 50,751 | $ | 44,607 | 13.8 | % | $ | 149,578 | $ | 130,445 | 14.7 | % | ||||||||
Industrial Technology | 100,735 | 43,213 | 133.1 | 294,814 | 126,816 | 132.5 | ||||||||||||||
Energy Systems & Controls | 42,807 | 41,621 | 2.8 | 111,145 | 105,260 | 5.6 | ||||||||||||||
Scientific & Industrial Imaging | 45,848 | 42,623 | 7.6 | 137,678 | 125,041 | 10.1 | ||||||||||||||
Total | $ | 240,141 | $ | 172,064 | 39.6 | % | $ | 693,215 | $ | 487,562 | 42.2 | % | ||||||||
Gross profit: | ||||||||||||||||||||
Instrumentation | $ | 28,049 | $ | 26,316 | 6.6 | % | $ | 85,809 | $ | 76,223 | 12.6 | % | ||||||||
Industrial Technology | 43,859 | 19,926 | 120.1 | 124,371 | 58,576 | 112.3 | ||||||||||||||
Energy Systems & Controls | 21,468 | 23,053 | (6.9 | ) | 58,059 | 55,253 | 5.1 | |||||||||||||
Scientific & Industrial Imaging | 26,195 | 23,875 | 9.7 | 76,785 | 67,006 | 14.6 | ||||||||||||||
Total | $ | 119,571 | $ | 93,170 | 28.3 | % | $ | 345,024 | $ | 257,058 | 34.2 | % | ||||||||
Operating profit*: | ||||||||||||||||||||
Instrumentation | $ | 9,233 | $ | 8,200 | 12.6 | % | $ | 27,063 | $ | 21,042 | 28.6 | % | ||||||||
Industrial Technology | 22,451 | 9,394 | 139.0 | 59,862 | 27,586 | 117.0 | ||||||||||||||
Energy Systems & Controls | 9,818 | 10,636 | (7.7 | ) | 21,467 | 19,591 | 9.6 | |||||||||||||
Scientific & Industrial Imaging | 8,268 | 8,097 | 2.1 | 22,648 | 20,796 | 8.9 | ||||||||||||||
Total | $ | 49,770 | $ | 36,327 | 37.0 | % | $ | 131,040 | $ | 89,015 | 47.2 | % | ||||||||
* Operating profit is before unallocated corporate general and administrative expenses. Such expenses were $4,350 and $3,806 for the three months ended September 30, 2004 and 2003, respectively, and $11,940 and $10,219 for the nine months ended September 30, 2004 and 2003, respectively.
During the transition period ended December 31, 2002, the Company formalized its decision to offer for sale the Petrotech operation. Petrotech was subsequently sold on August 31, 2003. Accordingly, related operating results reported as discontinued operations are outlined as follows (amounts in thousands):
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
2003 |
2004 |
2003 |
|||||||||||
Net sales | $ | -- | $ | 1,057 | $ | -- | $ | 4,304 | ||||||
Loss before income taxes | -- | (1,281 | ) | -- | (2,671 | ) | ||||||||
Income tax benefit/(expense) | -- | (631 | ) | -- | (151 | ) | ||||||||
Loss on discontinued operations | $ | -- | $ | (1,912 | ) | $ | -- | $ | (2,822 | ) | ||||
The Petrotech operation was previously reported in the Companys Energy Systems and Controls segment. The accompanying financial statements have been restated to conform to discontinued operations treatment for all historical periods presented.
In January 2004, the FASB issued FASB Staff Position No. FAS 106-1 (FSP 106-1) Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, which provides temporary guidance concerning the recently enacted Medicare Prescription Drug, Improvement and Modernization Act of 2003. SFAS No. 106, Employers Accounting for Postretirement Benefits Other Than Pensions, requires presently enacted changes in laws that will take effect in future periods to be taken into account in measuring current period postretirement benefit cost and the accumulated projected benefit obligation. The implementation of FSP 106-1 had no material impact on the Company
The Emerging Issues Task Force issued EITF 03-06, Participating Securities and the Two-Class Method under FASB Statement No. 128, Earnings per Share, effective for periods ending after March 31, 2004, regarding the computation of earnings per share by companies that have issued securities other than common stock that contractually entitle the holder to participate in dividends and earnings of the company when, and if, it declares dividends on its common stock. The Company does not have securities subject to the provisions of EITF 03-06 and, as such, the implementation of EITF 03-06 had no material impact on the Companys financial statements.
The EITF reached final consensus on EITF 04-08, The Effect of Contingently Convertible Debt on Diluted Earnings per Share, which will require convertible debt with a market price contingency to be included in diluted EPS calculations. The consensus should be applied to reporting periods ending after December 15, 2004. Management is in the process of assessing the implications of this new standard for the Company.
In June 2004, restricted stock awards for a total of 16,000 shares and a deferred stock award for 2,000 shares were awarded to the Companys non-management directors under the Companys equity compensation plans in which these directors participate. The restrictions on 50% of the restricted stock awards to a director will lapse upon his continuous service for six months following the grant, and the restrictions on the remaining 50% upon his continuous service for one year following the grant. Similarly, 50% of the deferred stock award will vest upon continuous service for six months and the remaining 50% will vest upon one year of continuous service. Directors who received restricted stock will have voting rights and receive dividends, but the shares may not be sold, assigned, transferred, pledged or otherwise encumbered. The deferred stock award shares will be issued without restrictions upon the completion of the applicable continuous service periods. A director who terminates his service before the applicable restricted or continuous service periods run will forfeit the right to receive the corresponding shares.
The fair value of the shares awarded by the restricted stock and deferred stock awards on the date of grant is amortized ratably over the vesting period. Unearned compensation on the June 2004 grant of the awards of $945,180 was recorded based on the market value of the shares on the date of grant and is generally being amortized over one year. The unamortized balance of unearned compensation on the awards is included as a separate component of stockholders equity.
Compensation expense of $354,444 was recorded during the three months ended September 30, 2004 for the awards.
In December, 2003, Roper issued $230 million of 3.75% subordinated convertible notes due 2034 at an original issue discount of 60.498% (the Convertible Notes). The Convertible Notes are subordinated in right of payment to all of our existing and future senior debt. Interest on the notes is payable semiannually on July 15 and January 15 until the year 2009. After that date, we will not pay cash interest on the notes prior to maturity unless contingent cash interest becomes payable. Instead, after January 15, 2009, interest will be recognized at the effective rate of 3.75% and will represent accrual of original issue discount, excluding any contingent cash interest that may become payable. We will pay contingent cash interest to the holders of the notes during any six month period commencing after January 15, 2009 if the average trading price of a note for a five trading day measurement period preceding the applicable six month period equals 120% or more of the sum of the issue price, accrued original issue discount and accrued cash interest, if any, for such note. The contingent cash interest payable per note in respect of any six month period will equal the annual rate of 0.25%. Holders may convert their notes into 6.211 shares of our common stock, subject to adjustment, only (1) if the sale price of our common stock reaches, or the trading price of the notes falls below, specified thresholds, (2) if the notes are called for redemption, or (3) if specified corporate transactions have occurred. Upon conversion, we will have the right to deliver, in lieu of our common stock, cash or common stock or a combination of cash and common stock. Holders may require us to purchase all or a portion of their notes on January 15, 2009 at a price of $395.02 per note, on January 15, 2014 at a price of $475.66 per note, on January 15, 2019 at a price of $572.76 per note, on January 15, 2024 at a price of $689.68 per note, and on January 15, 2029 at a price of $830.47 per note, in each case plus accrued cash interest, if any, and accrued contingent cash interest, if any. We may only pay the purchase price of such notes in cash and not in common stock. In addition, if we experience a change in control, each holder may require us to purchase for cash all or a portion of such holders notes at a price equal to the sum of the issue price plus accrued original issue discount for non-tax purposes, accrued cash interest, if any, and accrued contingent cash interest, if any, to the date of purchase.
On October 5, 2004, the Company entered into a definitive agreement to acquire TransCore Holdings, Inc. from an investor group led by KRG Capital Partners, L.L.C. in a transaction valued at approximately $600 million. The acquisition is expected to close in the fourth quarter of 2004.
The Company has received commitments from JPMorgan Chase Bank and Wachovia Bank, N.A. for a senior secured credit facility consisting of term loans and a revolving credit line, which will result in lower LIBOR spreads and an improved maturity structure. In addition, the Company plans to raise approximately $250 million of cash through the issuance of common stock. The Company expects to record a non-cash charge of approximately $5-6 million, net of tax, in the fourth quarter of 2004 to write-off deferred costs in connection with its existing senior credit facility.
Consummation of the new credit facility is subject to the negotiation and execution of definitive loan documentation and customary closing conditions. The actual components of the financing plan and the terms of the financings are subject to certain conditions in the commitment letter and prevailing market conditions at the time of the closing and may, as a result, be different from described above.
You should read the following discussion in conjunction with Managements Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2003 as filed with the Securities and Exchange Commission (SEC) and the notes to our Condensed Consolidated Financial Statements included elsewhere in this report.
Roper Industries, Inc. (Roper, we or us) is a diversified industrial company that designs, manufactures and distributes energy systems and controls, scientific and industrial imaging products and software, industrial technology products and instrumentation products and services. We market these products and services to selected segments of a broad range of markets including water and wastewater, oil and gas, research, power generation, medical, semiconductor, refrigeration, automotive, and general industry.
We pursue consistent and sustainable growth in earnings by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other carefully selected businesses. Our acquisitions have represented both financial bolt-ons and new strategic platforms. We strive for high cash and earnings returns from our acquisition investments. During the first nine months of 2004, our results of operations benefited from the acquisition of Neptune Technology Group Holdings, Inc. (NTGH) made on December 29, 2003. NTGH is comprised of Neptune Technology, a leader in the meter management market; DB Microware, providing various software products for utility markets; and DAP Technologies, a leading fully rugged computer provider. Neptune Technology and DB Microware are both reported in our Industrial Technology segment, and DAP Technologies is reported in our Scientific and Industrial Imaging segment. On June 7, 2004 we purchased the power generation business of R/D Tech, which complements Ropers existing business of nondestructive evaluation systems for power utilities and is reported in the Energy Systems and Controls segment.
Since 1993, and until this year, our most significant customer has been OAO Gazprom (Gazprom), a Russian enterprise that is the worlds largest gas provider. We have provided complex gas transmission pipeline controls and related services to Gazprom that represented at least 7% of our sales during the period 1993 to 2002. Our growth elsewhere and declines in Gazprom demand have resulted in Gazprom sales being less than 1% of total net sales during the early part of this year and we expect this level for the full year. We understand that Gazprom demand has declined due to hard currency liquidity issues and changes in their procurement practices, including the purchase of control systems from Russian OEM turbomachinery manufacturers. We supply control systems to certain of these OEMs.
Our consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). A discussion of our significant accounting policies can be found in the notes to our consolidated financial statements for the year ended December 31, 2003 included in our Annual Report.
GAAP offers acceptable alternative methods for accounting for certain issues affecting our financial results, such as determining inventory cost, depreciating long-lived assets, recognizing revenues and issuing stock options to employees. We have not changed the application of acceptable accounting methods or the significant estimates affecting the application of these principles in the last three years in a manner that had a material effect on our financial statements, except for the adoption of Statement of Financial Accounting Standards, or SFAS, No. 142, Goodwill and Other Intangible Assets.
The preparation of financial statements in accordance with GAAP requires the use of estimates, assumptions, judgments and interpretations that can affect the reported amounts of assets, liabilities, revenues and expenses, the disclosure of contingent assets and liabilities and other supplemental disclosures.
The development of accounting estimates is the responsibility of our management. Our management discusses those areas that require significant judgments with the audit committee of our board of directors. The audit committee discusses critical estimates with our external auditors and reviews all financial disclosures to be included in our filings with the SEC. Although we believe the positions we have taken with regard to uncertainties are reasonable, others might reach different conclusions and our positions can change over time as more information becomes available. If an accounting estimate changes, its effects are accounted for prospectively.
Our most significant accounting uncertainties are encountered in the areas of accounts receivable collectibility, inventory utilization, future warranty obligations, revenue recognition (percent of completion), income taxes and goodwill analysis. These issues, except for income taxes ( which are not allocated to our business segments), affect each of our business segments. These issues are evaluated primarily using a combination of historical experience, current conditions and relatively short-term forecasting.
Accounts receivable collectibility is based on the economic circumstances of customers and credits given to customers after shipment of products, including in certain cases, credits for returned products. Accounts receivable are regularly reviewed to determine customers who have not paid within agreed upon terms, whether these amounts are consistent with past experiences, what historical experience has been with amounts deemed uncollectible and the impact that current and near-term forecast economic conditions might have on collection efforts in general and with specific customers. The returns and other sales credit histories are analyzed to determine likely future rates for such credits. At September 30, 2004, our allowance for doubtful accounts receivable, sales returns and sales credits was $4.9 million, or 2.8% of total gross accounts receivable of $174.4 million. The amount of the reserve has remained consistent over the past four quarters.
We regularly compare inventory quantities on hand against anticipated future usage, which we determine as a function of historical usage or forecasts related to specific items in order to evaluate obsolescence and excessive quantities. When we use historical usage, this information is also qualitatively compared to business trends to evaluate the reasonableness of using historical information as an estimate of future usage. Business trends can change rapidly and these events can affect the evaluation of inventory balances. At September 30, 2004, inventory reserves for excess and obsolete inventory were $24.8 million, or 18.3% of gross first-in, first-out inventory cost. The amount of our inventory reserve is comparable to the prior year end amount and slightly higher as a percentage of gross first-in, first-out inventory cost.
Most of our sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. Future warranty obligations are evaluated using, among other factors, historical cost experience, product evolution and customer feedback. At September 30, 2004, the accrual for future warranty obligations was $5.3 million or 0.5% of annualized third quarter sales. The amount of our warranty reserve is comparable to the prior year end amount.
Net sales recognized under the percentage-of-completion method of accounting are estimated and dependent on a comparison of total costs incurred to date to total estimated costs for a project. During the third quarter of 2004, we recognized $2.8 million of net sales using this method. In addition, approximately $10.8 million of net sales related to unfinished percentage-of-completion contracts had yet to be recognized at September 30, 2004. Net sales accounted for under this method are generally not significantly different in profitability compared with net sales for similar products and services accounted for under other methods.
Income taxes can be affected by estimates of whether, and within which jurisdictions, future earnings will occur and how and when cash is repatriated to the United States, combined with other aspects of an overall income tax strategy. Additionally, taxing jurisdictions could retroactively disagree with our tax treatment of certain items, and some historical transactions have income tax effects going forward. Accounting rules require these future effects to be evaluated using current laws, rules and regulations, each of which can change at any time and in an unpredictable manner. We utilized an effective income tax rate of 28.1% in the third quarter, which is 190 basis points lower than the 30.0% rate used in the prior year third quarter. The current year quarter includes a one time credit of approximately $0.9 million from a research and development tax credit study related to prior years, which was completed during the quarter. We anticipate the Companys effective tax rate for the fourth quarter of 2004 to be approximately 30.5% exclusive of any effects of the TransCore acquisition expected to be completed during the fourth quarter of 2004.
The evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed annually. We perform this analysis during our fourth quarter.
General
The following tables set forth selected information for the periods indicated. Dollar amounts are in thousands and percentages are the particular line item shown as a percentage of net sales. Percentages may not foot due to rounding.
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
2003 |
2004 |
2003 |
|||||||||||
Net sales | ||||||||||||||
Instrumentation | $ | 50,751 | $ | 44,607 | $ | 149,578 | $ | 130,445 | ||||||
Industrial Technology | 100,735 | 43,213 | 294,814 | 126,816 | ||||||||||
Energy Systems & Controls | 42,807 | 41,621 | 111,145 | 105,260 | ||||||||||
Scientific & Industrial Imaging | 45,848 | 42,623 | 137,678 | 125,041 | ||||||||||
Total | $ | 240,141 | $ | 172,064 | $ | 693,215 | $ | 487,562 | ||||||
Gross profit: | ||||||||||||||
Instrumentation | 55.3 | % | 59.0 | % | 57.4 | % | 58.4 | % | ||||||
Industrial Technology | 43.5 | 46.1 | 42.2 | 46.2 | ||||||||||
Energy Systems & Controls | 50.2 | 55.4 | 52.2 | 52.5 | ||||||||||
Scientific & Industrial Imaging | 57.1 | 56.0 | 55.8 | 53.6 | ||||||||||
Total | 49.8 | 54.1 | 49.8 | 52.7 | ||||||||||
Selling, general & administrative expenses: | ||||||||||||||
Instrumentation | 37.1 | % | 40.6 | % | 39.3 | % | 42.3 | % | ||||||
Industrial Technology | 21.3 | 24.4 | 21.9 | 24.4 | ||||||||||
Energy Systems & Controls | 27.2 | 29.8 | 32.9 | 33.9 | ||||||||||
Scientific & Industrial Imaging | 39.1 | 37.0 | 39.3 | 37.0 | ||||||||||
Total | 29.1 | 33.0 | 30.9 | 34.5 | ||||||||||
Segment operating profit: | ||||||||||||||
Instrumentation | 18.2 | % | 18.4 | % | 18.1 | % | 16.1 | % | ||||||
Industrial Technology | 22.3 | 21.7 | 20.3 | 21.8 | ||||||||||
Energy Systems & Controls | 22.9 | 25.6 | 19.3 | 18.6 | ||||||||||
Scientific & Industrial Imaging | 18.0 | 19.0 | 16.4 | 16.6 | ||||||||||
Total | 20.7 | 21.1 | 18.9 | 18.3 | ||||||||||
Corporate administrative expenses | (1.8 | ) | (2.2 | ) | (1.7 | ) | (2.1 | ) | ||||||
Earnings from continuing operations | 18.9 | 18.9 | 17.2 | 16.2 | ||||||||||
Interest expense | (3.1 | ) | (2.3 | ) | (3.0 | ) | (2.6 | ) | ||||||
Other income / (expense) | -- | (0.1 | ) | -- | -- | |||||||||
Earnings from continuing operations before taxes | 15.9 | 16.4 | 14.1 | 13.5 | ||||||||||
Income taxes | (4.5 | ) | (4.9 | ) | (4.2 | ) | (4.1 | ) | ||||||
Earnings from continuing operations | 11.4 | 11.5 | 10.0 | 9.5 | ||||||||||
Loss from discontinued operations, net of tax | -- | (1.1 | ) | -- | (0.6 | ) | ||||||||
Net earnings | 11.4 | % | 10.4 | % | 10.0 | % | 8.9 | % | ||||||
Three months ended September 30, 2004 compared to three months ended September 30, 2003
Net sales for the quarter ended September 30, 2004 were $240.1 million as compared to $172.1 million in the prior year quarter, a 39.6% increase. Approximately $63.6 million of this increase was due to acquisitions, primarily NTGH completed on December 29, 2003, however, all of our segments showed improvement over the prior year quarter. Organic sales, excluding net sales to Gazprom, were $175.3 million for the three months ended September 30, 2004 compared to $164.6 million in the prior year quarter, a 6.5% increase. During the quarters ended September 30, 2004 and 2003 our net sales to Gazprom were $1.2 million and $7.4 million, respectively.
In our Industrial Technology segment, net sales were up 133.1% to $100.7 million in the third quarter of 2004 as compared to $43.2 million in the third quarter of 2003 due primarily to the inclusion of Neptune Technology and DB Microware in the current year quarter. Gross margins were lower at 43.5% for the third quarter of 2004 as compared to 46.1% in the third quarter of 2003. The decrease was primarily due to the Neptune margins being lower than the pre-acquisition segment average. SG&A expenses as a percentage of net sales were 21.3%, down from 24.4% in the prior year quarter. The reduction was primarily due to a lower SG&A structure for the Neptune business, but we also experienced some benefit from completed restructuring activities. The resulting operating profit margins were 22.3% in the third quarter of 2004 as compared to 21.7% in the third quarter of 2003.
In our Instrumentation segment, net sales were up $6.1 million or 13.8% as compared to the prior year quarter due to continued strength in petroleum and materials testing markets. Gross margins were 55.3% in the current quarter compared to 59.0% in the third quarter of 2003 due to lower margins being obtained in the petroleum testing portion of this segment. SG&A expenses as a percentage of net sales decreased to 37.1% in the current quarter, compared to 40.6% in the prior year quarter due to the benefits of completed restructuring activities. Overall, the segment reported operating profit margins of 18.2% as compared to 18.4% in the prior year quarter.
Net sales in our Energy Systems & Controls segment increased by 2.8% to $42.8 million during the third quarter of 2004 compared to the third quarter of 2003. Excluding sales to Gazprom, third quarter net sales increased 21.6% from $34.2 million to $41.6 million primarily due to the acquisition of the power generation business of R/D Tech, which had sales of $4.9 million, and strong activity in other oil & gas markets, offset somewhat by a $6.2 million reduction in sales to Gazprom. Gross margins decreased to 50.2% in the third quarter of 2004 compared to 55.4% in the third quarter of 2003 as a result of lower sales levels to Gazprom and negative product mix in our non-destructive evaluation business. SG&A expenses as a percentage of net sales were down slightly to 27.2% compared to prior year quarter at 29.8%. As a result, operating margins were 22.9% in the third quarter of 2004 as compared to 25.6% in third quarter of 2003.
Our Scientific & Industrial Imaging segment net sales increased by 7.6% due to the inclusion of sales of DAP Technologies, part of the NTGH acquisition. Gross margins improved from 56.0% in the third quarter of 2003 to 57.1% in the third quarter of 2004 due to a favorable mix of product sales. SG&A as a percentage of net sales was 39.1% in the third quarter of 2004 as compared to 37.0% in the third quarter of 2003. Overall, the segment reported operating profit margins of 18.0% as compared to 19.0% in the prior year quarter.
Corporate expenses were $4.4 million in the third quarter of 2004 as compared to $3.8 million in the third quarter of 2003. Additional governance costs were the primary factor behind the increase.
Interest expense of $7.3 million for the third quarter of 2004 was 82.4% higher as compared to the third quarter of 2003 interest expense of $4.0 million. This increase is due to the higher debt levels associated with the NTGH acquisition completed in December 2003, and increasing interest rates on the variable rate portion of our outstanding debt.
Income taxes were 28.1% of pretax earnings in the current quarter as compared to 30.0% in the third quarter of 2003. The current year quarter includes a one time credit of approximately $0.9 million from a research and development tax credit study related to prior years, which was completed during the quarter. We anticipate that our effective tax rate for the fourth quarter of 2004 will be approximately 30.5%, exclusive of any effects of the TransCore acquisition, which is expected to be completed during the fourth quarter of 2004.
At September 30, 2004, the functional currencies of our European subsidiaries were slightly stronger against the U.S. dollar compared to currency exchange rates at December 31, 2003 and September 30, 2003. The currency changes resulted in an increase of $4.3 million in the foreign exchange component of comprehensive earnings for the quarter. Approximately $3.0 million of the total adjustment related to goodwill and is not expected to directly affect our expected future cash flows. Operating results in the third quarter of 2004 benefited slightly from the weakening of the US dollar, primarily against the Euro. The difference between the operating results for these companies for the three months ended September 30, 2004, translated into U.S. dollars at average currency exchange rates experienced during the quarter and these operating results translated into U.S. dollars at average currency exchange rates experienced during the comparable quarter in 2003 was approximately 1.1%.
Net orders, booked from continuing operations, were $248.4 million for the quarter, 53.1% higher than the third quarter 2003 net order intake of $162.2 million. Approximately $69.0 million of the order increase was due to acquisitions, primarily NTGH, completed on December 29, 2003. We also experienced strong bookings in our Instrumentation Segment. Overall, our order backlog at September 30, 2004 was up 46.2% as compared to September 30, 2003. The increase is primarily in the Industrial Technology segment due to the Neptune Technology acquisition.
Net orders booked for the three months ended September 30, |
Order backlog as of September 30, |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 |
2003 |
2004 |
2003 |
|||||||||||
Instrumentation | $ | 55,282 | $ | 45,144 | $ | 20,505 | $ | 15,188 | ||||||
Industrial Technology | 101,875 | 40,315 | 56,275 | 25,909 | ||||||||||
Energy Systems & Controls | 47,826 | 37,676 | 36,474 | 26,261 | ||||||||||
Scientific & Industrial Imaging | 43,397 | 39,094 | 36,056 | 34,736 | ||||||||||
$ | 248,380 | $ | 162,229 | $ | 149,310 | $ | 102,094 | |||||||
Nine months ended September 30, 2004 compared to nine months ended September 30, 2003
Net sales for the nine month period ended September 30, 2004 were $693.2 million as compared to $487.6 million in the prior year quarter, a 42.2% increase. Approximately $176.8 million of this increase was due to acquisitions, primarily NTGH completed on December 29, 2003, however, all of our segments showed improvement over the prior year period.
In our Industrial Technology segment, net sales were up 132.5% to $294.8 million in the first nine months of 2004 as compared to $126.8 million in the first nine months of 2003 due primarily to the inclusion of Neptune Technology and DB Microware in the current year period. Gross margins were lower at 42.2% for the first nine months of 2004 as compared to 46.2% in the first nine months of 2003. The decrease was primarily due to the Neptune margins being lower than the pre-acquisition segment average. Additionally, Neptune margins were adversely impacted by the inclusion of approximately $1.5 million in cost of goods sold during the first quarter related to purchase accounting that will not recur in future quarters. Also, the first quarter of 2004 included $0.3 million of restructuring costs included in cost of goods sold which are not expected to recur. SG&A expenses as a percentage of net sales were 21.9%, down from 24.4% in the prior year period. The reduction was primarily due to a lower SG&A structure for the Neptune business. Also, the first quarter of 2004 included $0.7 million of restructuring included in SG&A which is not expected to recur. The resulting operating profit margins were 20.3% in the first nine months of 2004 as compared to 21.8% in the first nine months of 2003.
In our Instrumentation segment, net sales were $149.6 million as compared to $130.4 million in the prior year period, up $19.2 million or 14.7%. This segment experienced increased revenues from our foreign sales attributable to the stronger Euro and increased sales in certain petroleum and materials testing markets. Gross margins decreased to 57.4% in the current period from 58.8% in the first nine months of 2003 with lower margins being experienced in the most recent quarter in our petroleum testing businesses. SG&A expenses as a percentage of net sales were lowered to 39.3% in the current period, compared to 42.3% in the prior year period as benefits were realized from restructuring activities. Overall the segment reported operating profit margins of 18.1% as compared to 16.1% in the prior year period.
Net sales in our Energy Systems & Controls segment increased by 5.6% to $111.1 million during the first nine months of 2004, compared to $105.3 million in the first nine months of 2003 due to the inclusion in the third quarter of the first full quarter results of the acquisition of the power generation business of R/D Tech, as well as strong performance in our power utility maintenance and oil & gas markets, offset somewhat by a $14.2 million reduction in sales to Gazprom. Gross margins decreased slightly to 52.2% in the first nine months of 2004 compared to 52.5% in the first nine months of 2003. SG&A expenses decreased to 32.9% in the current nine month period as compared to 33.3% in the prior year period. As a result, operating margins were 19.3% in the first nine months of 2004 as compared to 18.6% in first nine months of 2003.
Our Scientific & Industrial Imaging segment net sales increased by 10.1% to $137.7 million in the nine months ended September 30, 2004 as compared to $125.0 million in the prior year period due primarily to the inclusion of sales of DAP Technologies, part of the NTGH acquisition. Gross margins improved from 53.6% in the first nine months of 2003 to 55.8% in the first nine months of 2004 due to strength in imaging equipment sales. SG&A as a percentage of net sales was 39.3% in the first nine months of 2004 as compared to 37.0% in the first nine months of 2003. Overall, the segment reported operating profit margins of 16.4% as compared to 16.6% in the prior year nine month period.
Corporate expenses were $11.9 million in the first nine months of 2004 as compared to $10.2 million in the first nine months of 2003. Additional governance costs and variable compensation expenses were the primary factors behind the increase.
Interest expense of $21.1 million for the first nine months of 2004 was 66.5% higher as compared to the first nine months of 2003 interest expense of $12.7 million. This increase is primarily due to the higher debt levels associated with the NTGH acquisition completed in December 2003.
Income taxes were 29.6% of pretax earnings in the period ended September 30, 2004 as compared to 30.0% in the prior year period ended September 30, 2003. This decrease includes a one time credit of approximately $0.9 million related to a research and development tax credit study as well as the offsetting impact of the NTGH businesses acquired in the fourth quarter of 2003 and the capital restructuring completed in conjunction with that acquisition.
Net cash provided by operating activities was $35.6 million in the third quarter of 2004 as compared to $21.2 million in the third quarter of 2003, a 67.6% increase. This increase is attributable to the inclusion of NTGH in the current year results, better performance of our business units, successful implementation of our restructuring efforts, and our continued focus on working capital reduction. Cash used by financing activities during the current and prior year quarter resulted primarily from dividend and debt payments.
Net cash provided by operating activities in the first nine months of 2004 of $101.6 million was 75.8% higher than in the equivalent nine month period of 2003 primarily due to the reasons noted above.
In January 2004, an underwriters overallotment of 630,000 shares of common stock was exercised and closed, providing the Company with gross proceeds of approximately $30.2 million before expenses.
$35.0 million of debt was repaid over the nine months ended September 30, 2004 as compared with $45.8 million in the prior year period. The Company completely repaid its revolving credit facility balance of $20.0 million that was outstanding subsequent to the closing of the NTGH acquisition. In addition, $15.0 million of principal payments on the Companys $400.0 million term loan were made in accordance with the terms of the credit facility.
Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was $180.8 million at September 30, 2004 compared to $170.4 million at December 31, 2003, reflecting the decrease in certain accrued liabilities that existed at year end related to the NTGH acquisition. Total debt was $615.7 million at September, 2004 compared to $651.1 million at December 31, 2003. The leverage of the Company improved as shown in the following table:
September 30, 2004 |
December 31, 2003 |
|||||||
---|---|---|---|---|---|---|---|---|
Total Debt | $ | 615,697 | $ | 651,109 | ||||
Cash | (102,416 | ) | (70,234 | ) | ||||
Net Debt | 513,281 | 580,875 | ||||||
Stockholders' Equity | 755,506 | 655,781 | ||||||
Total Net Capital | $ | 1,268,787 | $ | 1,236,656 | ||||
Net Debt / Total Net Capital | 40.5 | % | 47.0 | % |
Our debt consists of a $625 million senior secured credit facility with a diverse group of participating financial institutions and banks, and $230 million of senior subordinated convertible notes. The credit facility consists of a $400 million amortizing term loan with a five year maturity and a $225 million revolving loan with a three year maturity. Our senior subordinated convertible notes are due in 2034. At September 30, 2004, our debt consisted of the $230 million in senior subordinated convertible notes and $385 million of term loans under the credit facility. The Company also had $15.3 million of outstanding letters of credit at September 30, 2004. We expect that our available additional borrowing capacity combined with the cash flows expected to be generated from existing business will be sufficient to fund normal operating requirements and finance some additional acquisitions. We also have several smaller facilities that allow for borrowings or the issuance of letters of credit in various foreign locations to support our non-U.S. businesses. In total, these smaller facilities do not represent a significant source of credit for us.
We were in compliance with all debt covenants related to our credit facilities throughout the quarter ended September 30, 2004.
At September 30, 2004, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Capital expenditures of $3.0 million and $3.2 million were incurred during the third quarters of 2004 and 2003 respectively. We expect capital expenditures for the balance of the year to be comparable to prior years as a percentage of sales.
Corporate governance costs during the fourth quarter of 2004 are expected to be significantly higher than the fourth quarter of 2003 due to costs associated with compliance with Section 404 of the Sarbanes-Oxley Act of 2002.
In January 2004, the FASB issued FASB Staff Position No. FAS 106-1 (FSP 106-1) Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, which provides temporary guidance concerning the recently enacted Medicare Prescription Drug, Improvement and Modernization Act of 2003. SFAS No. 106, Employers Accounting for Postretirement Benefits Other Than Pensions, requires presently enacted changes in laws that will take effect in future periods to be taken into account in measuring current period postretirement benefit cost and the accumulated projected benefit obligation. The implementation of FSP 106-1 had no material impact on the Company
The Emerging Issues Task Force issued EITF 03-06, Participating Securities and the Two-Class Method under FASB Statement No. 128, Earnings per Share, effective for periods ending after March 31, 2004, regarding the computation of earnings per share by companies that have issued securities other than common stock that contractually entitle the holder to participate in dividends and earnings of the company when, and if, it declares dividends on its common stock. The Company does not have securities subject to the provisions of EITF 03-06 and the implementation of EITF 03-06 had no material impact on the Companys financial statements.
The EITF reached final consensus on EITF 04-08, The Effect of Contingently Convertible Debt on Diluted Earnings per Share, which will require convertible debt with a market price contingency to be included in diluted EPS calculations. The consensus should be applied to reporting periods ending after December 15, 2004. Management is in the process of assessing the implications of this new standard for the Company.
Current geopolitical uncertainties could adversely affect our business prospects. A significant terrorist attack or other global conflict could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these factors effects on current economic conditions. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also will similarly disrupt the economy.
We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, the proceeds from the issuance of new debt or equity securities or some combination of these methods.
We anticipate that our recently acquired companies as well as our other companies will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt at a pace consistent with that which has historically been experienced. However, the rate at which we can reduce our debt during 2004 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions and the financial performance of our existing companies; and none of these factors can be predicted with certainty.
This report includes forward-looking statements within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the SEC or in oral statements made to the press, potential investors or others. All statements that are not historical facts are forward-looking statements. The words estimate, project, intend, expect, should, will, plan, believe, anticipate, and similar expressions identify forward-looking statements. These forward-looking statements include statements regarding our expected financial position, business, financing plans, business strategy, business prospects, revenues, working capital, liquidity, capital needs, interest costs and income, in each case relating to our company as a whole, as well as statements regarding acquisitions, potential acquisitions and the benefits of acquisitions, including with respect to the NTGH and TransCore acquisitions.
Forward-looking statements are estimates and projections reflecting our best judgment and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These statements are based on our managements beliefs and assumptions, which in turn are based on currently available information. Examples of forward looking statements in this report include but are not limited to our expectations regarding our ability to generate operating cash flows and reduce debt and associated interest expense and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, timing and success of product upgrades and new product introductions, raw materials costs, expected pricing levels, the timing and cost of expected capital expenditures, expected outcomes of pending litigation, competitive conditions, general economic conditions and expected synergies relating to acquisitions, joint ventures and alliances. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include:
Section 404 of the Sarbanes-Oxley Act of 2002 requires that management evaluate and report on the effectiveness of our internal controls over financial reporting and provide management's assessment of the effectiveness of internal control over financial reporting in our Annual Report on Form 10-K for the year ended December 31, 2004. Our independent auditors also must attest to, and report on, managements assessment of our internal controls over financial reporting.
We are in the process of evaluating our internal controls over financial reporting. As part of this process, we have invested a substantial amount of time and resources in documenting and testing our system of internal control. We have not identified any material weakness, but management has identified certain internal control issues that we believe need to be improved. As a result, we have made improvements to our internal controls and will continue to do so. Based on our current knowledge, we believe that our documentation, testing and final assessment of our internal controls over financial reporting will be completed on a timely basis. However, there can be no assurance that one or more deficiencies will not constitute what we or our independent auditors conclude is a material weakness in internal control over financial reporting or that we will be able to complete the process in time to allow our independent auditors to finish their assessment and issue their report on a timely basis.
We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.
We are exposed to interest rate risks on our outstanding borrowings, and we are exposed to foreign currency exchange risks on our transactions denominated in currencies other than the U.S. dollar. We are also exposed to equity market risks pertaining to the traded price of our common stock.
At September 30, 2004 we had a combination of fixed-rate borrowings (primarily our $230 million senior subordinated convertible notes) and primarily variable rate borrowings under the $625 million credit facility. Our $400 million 5-year term note under this credit facility was variable at a spread over LIBOR. Any borrowings under the $225 million revolving credit facility have a fixed rate, but the terms of these individual borrowings are generally only one to three months. During the first quarter of 2004, we fixed the interest rate at 4.108% on $100 million of the term note for a period of two years. At September 30, 2004, there was no material difference between prevailing market rates and the fixed rate on our debt instruments.
At September 30, 2004, Ropers outstanding variable-rate borrowings under the $625 million credit facility were $285 million. An increase in interest rates of 1% would increase our annualized interest costs by approximately $2.9 million.
Several Roper companies have transactions and balances denominated in currencies other than the U.S. dollar. Most of these transactions or balances are denominated in Euros, British pounds, Danish krone or Japanese yen. Sales by companies whose functional currency was not the U.S. dollar were 32.9% of our total third quarter sales and 78.7% of these sales were by companies with a European functional currency. The U.S. dollar weakened against these European currencies during the third quarter of 2004 and was relatively stable compared to other currencies. The difference between the current quarter operating results for these companies translated into U.S. dollars at average currency exchange rates experienced during third-quarter 2004 and these operating results translated into U.S. dollars at average currency exchange rates experienced during third-quarter 2003 was not material and resulted in increased operating profits of approximately 1.1%. If these currency exchange rates had been 10% different throughout the third quarter of 2004 compared to currency exchange rates actually experienced, the impact on our expected net earnings would have been approximately $0.7 million.
The changes in these currency exchange rates relative to the U.S. dollar during the third quarter of 2004 compared to currency exchange rates at June 30, 2004 resulted in an increase in net assets of $4.3 million that was reported as a component of comprehensive earnings, $3.0 million of which was attributed to goodwill. Goodwill changes from currency exchange rate changes do not directly affect our reported earnings or cash flows.
The trading price of Ropers common stock influences the valuation of stock option grants and the effects these grants have on pro forma earnings disclosed in our financial statements. The stock price also influences the computation of the dilutive effect of outstanding stock options to determine diluted earnings per share. The stock price also affects our employees perceptions of various programs that involve our common stock. We believe the quantification of the effects of these changing prices on our future earnings and cash flows is not readily determinable.
As required by Securities and Exchange Commission rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation, these officers have concluded that the design and operation of our disclosure controls and procedures are effective. There were no changes to our internal controls during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
Disclosure controls and procedures are our controls and other procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commissions rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
(a)3.1 | Restated Certificate of Incorporation, including Form of Certificate of Designation, Preferences and Rights of Series A Preferred Stock | ||||
(b)3.2 | Amended and Restated By-Laws | ||||
(c)4.1 | Rights Agreement between Roper Industries, Inc. and SunTrust Bank, Atlanta, Inc. as Rights Agent, dated as of January 8, 1996, including Certificate of Designation, Preferences and Rights of Series A Preferred Stock (Exhibit A), Form of Rights Certificate (Exhibit B) and Summary of Rights (Exhibit C) | ||||
(d)4.2 | Form of Indenture for Debt Securities. | ||||
4.3 | Form of Debt Securities (included in Exhibit 4.4). | ||||
(e)4.4 | First Supplemental Indenture between Roper Industries, Inc. and SunTrust Bank, dated as of December 29, 2003. | ||||
31.1 | Certification of Chief Executive Officer and Acting Chief Financial Officer (302) | ||||
32.1 | Certification of Chief Executive Officer and Acting Chief Financial Officer (906) |
(a) | Incorporated herein by reference to Exhibit 3.1 to the Roper Industries, Inc. Quarterly Report on Form 10-Q filed March 17, 2003. |
(b) | Incorporated herein by reference to Exhibit 3.2 to the Roper Industries, Inc. Quarterly Report on Form 10-Q filed September 13, 2000. |
(c) | Incorporated herein by reference to Exhibit 4.02 to the Roper Industries, Inc. Current Report on Form 8-K filed January 18, 1996 (File No. 0-19818). |
(d) | Incorporated herein by reference to Exhibit 4.2 to the Roper Industries, Inc. Pre-Effective Amendment No. 1 to the Registration Statement on Form S-3 filed November 28, 2003 (File No. 333-110491). |
(e) | Incorporated herein by reference to Exhibit 4.1 to the Roper Industries, Inc. Current Report on Form 8-K filed January 13, 2004. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Signature |
Title |
Date |
---|---|---|
/s/ Brian D. Jellison | Chairman of the Board, President, | November 5, 2004 |
Brian D. Jellison | Chief Executive Officer and | |
Acting Chief Financial Officer | ||
(Principal Executive Officer) | ||
(Principal Financial Officer) | ||
/s/ Paul J. Soni | Director of Accounting | November 5, 2004 |
Paul J. Soni | (Principal Financial Officer) |
EXHIBIT INDEX TO REPORT ON FORM 10-Q
Number | Exhibit |
3.1 | Restated Certificate of Incorporation, including Form of Certificate of Designation, Preferences and Rights of Series A Preferred Stock, incorporated herein by reference to Exhibit 3.1 to the Roper Industries, Inc. Quarterly Report on Form 10-K filed March 17, 2003. |
3.2 | Amended and Restated By-Laws, incorporated herein by reference to Exhibit 3.2 to the Roper Industries, Inc. Quarterly Report on Form 10-Q filed September 13, 2000. |
4.1 | Rights Agreement between Roper Industries, Inc. and SunTrust Bank, Atlanta, Inc. as Rights Agent, dated as of January 8, 1996, including Certificate of Designation, Preferences and Rights of Series A Preferred Stock (Exhibit A), Form of Rights Certificate (Exhibit B) and Summary of Rights (Exhibit C), incorporated herein by reference to Exhibit 4.02 to the Roper Industries, Inc. Current Report on Form 8-K filed January 18, 1996 (File No. 0-19818). |
4.2 | Form of Indenture for Debt Securities incorporated herein by reference to Exhibit 4.2 to the Roper Industries, Inc. Pre-Effective Amendment No. 1 to the Registration Statement on Form S-3 filed November 28, 2003 (File No. 333-110491). |
4.3 | Form of Debt Securities (included in Exhibit 4.4). |
4.4 | First Supplemental Indenture between Roper Industries, Inc. and SunTrust Bank, dated December 29, 2003 incorporated herein by reference to Exhibit 4.1 to the Roper Industries, Inc. Current Report on Form 8-K filed on January 13, 2004. |
31.1 | Certification of Chief Executive Officer and Acting Chief Financial Officer (302) |
32.1 | Certification of Chief Executive Officer and Acting Chief Financial Officer (906) |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Roper Industries, Inc. (the Company) on Form 10-Q for the period ending September 30, 2004, as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officers knowledge:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 5, 2004 | /s/ Brian D. Jellison |
Brian D. Jellison | |
Chairman of the Board, President | |
Chief Executive Officer and | |
Acting Chief Financial Officer | |
(Principal Executive Officer) | |
(Principal Financial Officer) |
Exhibit 31.1
I, Brian D. Jellison, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Roper Industries, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and |
c) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: November 5, 2004 | /s/ Brian D. Jellison |
Brian D. Jellison | |
Chairman of the Board, President | |
Chief Executive Officer and | |
Acting Chief Financial Officer | |
(Principal Executive Officer) | |
(Principal Financial Officer) |